Advertisement

Topics

Chris Boshoff, Chief Development Officer, Oncology, had the honor of helping plan the @NYASciences Frontiers in Cancer Immunotherapy Symposium where experts discussed cutting edge findings in the broad area of combo therapies. #immunotherapy2019 http://b

15:31 EDT 17 May 2019 | Pfizer

Chris Boshoff, Chief Development Officer, Oncology, had the honor of helping plan the Frontiers in Cancer Immunotherapy Symposium where experts discussed cutting edge findings in the broad area of combo therapies. http://bit.ly/2YA9zIx 

Original Article: Chris Boshoff, Chief Development Officer, Oncology, had the honor of helping plan the @NYASciences Frontiers in Cancer Immunotherapy Symposium where experts discussed cutting edge findings in the broad area of combo therapies. #immunotherapy2019 http://b

NEXT ARTICLE

More From BioPortfolio on "Chris Boshoff, Chief Development Officer, Oncology, had the honor of helping plan the @NYASciences Frontiers in Cancer Immunotherapy Symposium where experts discussed cutting edge findings in the broad area of combo therapies. #immunotherapy2019 http://b"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...